Why the study?
High-fat diet-induced obesity is a crucial risk factor for metabolic syndrome, but the underlying mechanisms linking adipose tissue dysfunction to obesity remain unclear.
Does targeting lncRNA LINK-A via antisense oligonucleotides attenuate high-fat diet-induced obesity and metabolic syndrome in preclinical models?
Does targeting lncRNA LINK-A via antisense oligonucleotides attenuate high-fat diet-induced obesity and metabolic syndrome in preclinical models?
The lncRNA LINK-A promotes HFD-induced obesity by remodeling the inflammatory microenvironment, and its targeted inhibition via ASO represents a potential therapeutic strategy for metabolic syndrome.
Identifies a novel lncRNA-directed therapeutic target for metabolic syndrome;.
High-fat diet (HFD)-induced obesity is a crucial risk factor for metabolic syndrome, mainly due to adipose tissue dysfunctions associated with it. However, the underlying mechanism remains unclear. This study has used genetic screening to identify an obesity-associated human lncRNA LINK-A as a critical molecule bridging the metabolic microenvironment and energy expenditure in vivo by establishing the HFD-induced obesity knock-in (KI) mouse model. Mechanistically, HFD LINK-A KI mice induce the infiltration of inflammatory factors, including IL-1β and CXCL16, through the LINK-A/HB-EGF/HIF1α feedback loop axis in a self-amplified manner, thereby promoting the adipose tissue microenvironment remodeling and adaptive thermogenesis disorder, ultimately leading to obesity and insulin resistance. Notably, LINK-A expression is positively correlated with inflammatory factor expression in individuals who are overweight. Of note, targeting LINK-A via nucleic acid drug antisense oligonucleotides (ASO) attenuate HFD-induced obesity and metabolic syndrome, pointing out LINK-A as a valuable and effective therapeutic target for treating HFD-induced obesity. Briefly, the results reveale the roles of lncRNAs (such as LINK-A) in remodeling tissue inflammatory microenvironments to promote HFD-induced obesity.
No takes yet. Share an insight, caveat, or question.
Chen et al. (2023) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: